Who owns Vertex Pharmaceuticals Incorporated?

Key details on Vertex Pharmaceuticals Incorporated (Ticker: VRTX)

Who owns Vertex Pharmaceuticals Incorporated?

Is VRTX a good stock to own? Find out who bought Vertex Pharmaceuticals Incorporated, who sold Vertex Pharmaceuticals Incorporated (VRTX) stock, and who holds a large position in Vertex Pharmaceuticals Incorporated.

Fund Name Number of Shares Share Valuation As Of
Capital World Investors^ 25.52M $1.90B Dec. 31, 2013
Vanguard 16.39M $1.16B March 31, 2014
Wellington Management Company 16.28M $1.15B March 31, 2014
Jennison Associates 12.85M $909.04M March 31, 2014
T. Rowe Price Associates 11.83M $836.26M March 31, 2014
STATE STREET CORPORATION 10.09M $713.87M March 31, 2014
Ameriprise Financial 8.13M $574.65M March 31, 2014
JPMORGAN CHASE & CO 7.61M $537.95M March 31, 2014
ClearBridge Advisors 7.26M $513.24M March 31, 2014
FMR 6.61M $467.37M March 31, 2014
BlackRock Institutional Trust Company, N.A. 6.03M $426.74M March 31, 2014
BlackRock Fund Advisors 5.89M $416.22M March 31, 2014
Janus Capital Management 5.09M $405.72M June 30, 2013
GOLDMAN SACHS 4.60M $325.31M March 31, 2014
D. E. Shaw & Co 4.22M $235.76M June 30, 2012
Westfield Capital Management Company 3.88M $159.16M March 31, 2012
Neuberger Berman 3.74M $156.63M Dec. 31, 2012
ALLIANCEBERNSTEIN 3.72M $152.74M March 31, 2012
Waddell & Reed Financial 3.61M $255.23M March 31, 2014
Sectoral Asset Management 3.49M $192.02M March 31, 2013
OppenheimerFunds 3.48M $246.41M March 31, 2014
Loomis, Sayles and 3.46M $244.68M March 31, 2014
Brookside Capital Management, LLC* 3.42M $113.48B Dec. 31, 2011
Lazard Asset Management 3.34M $248.34M Dec. 31, 2013

Who sold Vertex Pharmaceuticals Incorporated?

Fund Name Date Sold Number of Shares Sold Share Valuation
BB Biotech AG March 31, 2011 3.95M $189.32M